Wegovy tablet side effects — what to expect and how to manage them

# Wegovy tablet side effects — what to expect and how to manage them

Side effects are one of the first things people want to understand before starting oral Wegovy. The honest answer is that gastrointestinal symptoms are common, particularly in the early weeks of treatment and after each dose increase. They are also, for most people, temporary.

This guide walks through what the OASIS 2 trial data shows about the frequency and severity of side effects, when symptoms are most likely to peak, practical strategies for managing nausea and other GI complaints, and which symptoms warrant contacting your prescriber promptly.

The aim is not to discourage people who might benefit from treatment — the side effect profile is broadly manageable and the majority of trial participants who experienced GI symptoms did not discontinue because of them. The aim is to give you accurate expectations so that if you do experience nausea in week two after a dose increase, you know it is expected, likely to improve, and something you can manage rather than a sign that the medicine is not working or has caused a serious problem.

> Wegovy tablets are a prescription-only medicine. Always consult a qualified healthcare professional before starting or changing treatment. If you experience any severe or concerning symptoms while taking oral semaglutide, contact your prescriber or seek medical advice promptly.

—

## The most common side effects: gastrointestinal

The most commonly reported side effects with oral semaglutide are gastrointestinal — affecting the digestive system from stomach to bowel. In the OASIS 2 trial, GI side effects were the most frequent reason for dose adjustments and the most common reason for discontinuation, though overall discontinuation rates due to adverse events were modest.

The main GI side effects reported in trials include:

– **Nausea** — the most frequently reported, experienced by a significant proportion of participants particularly after dose increases
– **Vomiting** — less frequent than nausea but reported by a meaningful minority, especially at higher doses
– **Diarrhoea** — reported variably, tends to be worse in early weeks
– **Constipation** — can occur alongside or as an alternative to diarrhoea; GLP-1 medicines slow gastric emptying, which affects bowel transit
– **Stomach pain and cramping** — often related to gastric slowing and gas accumulation
– **Burping and reflux (GERD)** — slowed gastric emptying means food stays in the stomach longer, increasing the likelihood of acid reflux and belching
– **Bloating and flatulence** — common, related to the same gastric motility changes

These symptoms vary considerably between individuals. Some people sail through the entire escalation schedule with mild or no nausea. Others find the first few weeks at each new dose level genuinely uncomfortable. Both experiences are within the normal range reported in trials.

—

## When side effects are worst: the dose-escalation pattern

Understanding the timing of side effects is important because it helps you interpret what you are experiencing.

GI side effects with semaglutide tend to follow a predictable pattern:

**They are worst in the first one to two weeks after a dose increase.** Each time your dose steps up — from 1.5mg to 4mg, from 4mg to 9mg, from 9mg to 25mg — your body needs time to adjust to the higher level of GLP-1 receptor activity. This adjustment period is when nausea and GI discomfort are most prominent.

**They typically improve substantially by weeks three and four at each dose level.** Your body habituates. Most people who experience significant nausea after a dose increase find that it reduces noticeably within two to three weeks, even without any specific intervention.

**The maintenance dose (25mg) can take longer to fully adjust to**, given that it represents the largest step up. Allow four to six weeks at maintenance before concluding that side effects are not improving.

If side effects remain severe and do not improve after two to three weeks at a given dose, discuss with your prescriber whether the escalation schedule should be slowed — spending more time at an intermediate dose before stepping up.

—

## Managing nausea: practical strategies

Nausea from oral Wegovy is primarily driven by slowed gastric emptying and increased GLP-1 receptor activation in the gut and brainstem. It cannot be eliminated, but it can be managed.

**Eat smaller, more frequent meals.** A large meal sitting in a slowed stomach is more likely to cause nausea and reflux. Splitting your daily food intake into four or five smaller portions is more comfortable than three large meals while your body is adjusting.

**Avoid foods that are hard to digest.** Fatty, fried, and heavily spiced food take longer to leave the stomach under normal circumstances — they take even longer when semaglutide is slowing gastric motility. During the worst side-effect periods, bland, easily digestible food is genuinely helpful: plain rice, toast, boiled potatoes, soup.

**Eat slowly and stop before you feel full.** One of the intended mechanisms of semaglutide is enhanced satiety — you feel full sooner. If you eat at your previous pace and previous portion size, you may overfill a stomach that is emptying slowly. Eating to the point of early fullness, and stopping, reduces the risk of nausea.

**Stay upright after eating.** Lying down after a meal increases reflux risk even without semaglutide. With semaglutide slowing gastric emptying, the advice is more important. Remain upright for at least an hour after eating.

**Ginger.** Ginger has a reasonable evidence base as an antiemetic for mild to moderate nausea, and it has no interactions with semaglutide. Ginger tea, crystallised ginger, or ginger biscuits (in modest quantities) are worth trying during the worst nausea periods.

**Stay hydrated.** Vomiting and reduced appetite can both lead to underhydration. Sip water throughout the day — small amounts frequently rather than large amounts at once.

**Anti-nausea medication.** If nausea is significantly affecting your quality of life, speak to your prescriber. Over-the-counter antiemetics (such as cyclizine or promethazine) may be appropriate in the short term. Do not self-medicate with prescription antiemetics without guidance.

—

## Reflux and burping

Reflux is a common complaint with oral semaglutide, and it can be more disruptive than nausea for some people. Slowed gastric emptying means acid-containing stomach contents are more likely to move upward.

Management strategies:
– Avoid eating within two to three hours of lying down or sleeping
– Elevate the head of your bed slightly if night-time reflux is a problem
– Avoid large quantities of caffeine, alcohol, chocolate, and acidic foods during adjustment periods — all of these relax the lower oesophageal sphincter
– Over-the-counter antacids or H2 blockers (such as famotidine, available without prescription) can help manage breakthrough reflux symptoms; discuss with your pharmacist

If reflux symptoms are severe or do not improve, this warrants a conversation with your prescriber. In some cases, a proton pump inhibitor (such as omeprazole) may be appropriate during the dose escalation period.

—

## Less common side effects

Beyond GI symptoms, OASIS 2 participants reported a range of less common side effects:

– **Headache** — reported more frequently in the semaglutide group than placebo, though in the majority of cases mild
– **Fatigue** — some participants reported increased tiredness, particularly early in treatment
– **Dizziness** — occasionally reported; may be related to reduced food intake or fluid intake rather than a direct drug effect
– **Reduced appetite** — this is an intended mechanism rather than a side effect in the traditional sense, but for some people it is more pronounced than expected and can affect adequate nutrition

—

## Rare but serious: what to watch for

The following symptoms are uncommon but require prompt medical attention if they occur:

### Pancreatitis

Acute pancreatitis has been reported with GLP-1 receptor agonist medicines, including semaglutide. The characteristic symptoms are severe abdominal pain, often radiating through to the back, that does not resolve with over-the-counter pain relief and may be accompanied by nausea and vomiting.

**If you experience severe upper abdominal pain, particularly radiating to the back, stop taking oral Wegovy and seek medical advice promptly.** Do not wait to see if it improves.

### Gallstones

Rapid weight loss of any cause is associated with an increased risk of gallstone formation. GLP-1 receptor agonists, including semaglutide, have been associated with gallbladder-related events in trials. Symptoms of gallstones include right upper abdominal pain, particularly after fatty meals, sometimes radiating to the right shoulder. Report these symptoms to your prescriber.

### Thyroid concerns

Animal studies (in rodents) found an association between semaglutide and medullary thyroid carcinoma (MTC). This association has not been demonstrated in humans, but as a precaution, oral Wegovy is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Your prescriber will screen for this before prescribing. Tell your prescriber about any family history of thyroid cancer.

### Severe allergic reaction

Anaphylaxis or severe hypersensitivity reactions are rare but possible with any medicine. Symptoms include swelling of the face, lips, tongue or throat, difficulty breathing, and widespread rash. Seek emergency medical attention immediately.

—

## When to stop and call your prescriber

Contact your prescriber or seek medical advice if you experience:

– Severe or persistent vomiting that prevents adequate fluid intake
– Signs of dehydration (dark urine, dizziness, very dry mouth)
– Severe abdominal pain, particularly radiating to the back
– Yellowing of the skin or whites of the eyes (jaundice)
– Rapid heartbeat at rest
– Persistent severe symptoms that are not improving after two to three weeks at your current dose

For any life-threatening symptoms, call 999 or go to A&E immediately.

—

## How oral Wegovy side effects compare to the injection

The injectable form of Wegovy (semaglutide 2.4mg weekly subcutaneous injection) has a similar GI side effect profile — nausea, vomiting, diarrhoea, and constipation are the most commonly reported with injectable semaglutide too.

One practical difference is that the injection delivers a weekly bolus of semaglutide, creating a weekly peak in blood levels followed by a gradual taper. The tablet delivers daily doses, meaning blood levels are more uniform but the daily absorption variability (depending on adherence to the fasting protocol) can create more day-to-day variation in symptom intensity. Some people find this means nausea comes and goes more unpredictably with the tablet compared to the injection.

Both formulations can cause the same serious rare events — pancreatitis, gallbladder issues — and the same contraindications apply.

—

## The bigger picture: most people manage well

The OASIS 2 trial completed with the large majority of participants in the semaglutide group still taking the medicine at 68 weeks. Discontinuation due to adverse events occurred in a minority of participants. This is worth keeping in mind: GI side effects are common, but they are usually temporary, manageable, and not a reason to stop treatment for most people.

The dose-escalation schedule that oral Wegovy follows — starting at 1.5mg and building over twelve weeks to 25mg — exists precisely to reduce the incidence and severity of side effects compared to starting at the full maintenance dose. Following this schedule, and taking the medicine correctly according to the fasting instructions, gives you the best chance of managing the adjustment period with minimal disruption.

—

## Frequently asked questions

### How common is nausea with oral Wegovy tablets?

Nausea is the most frequently reported side effect of oral semaglutide and was seen in a significant proportion of OASIS 2 trial participants, particularly after dose increases. The majority of cases were mild to moderate and improved as participants habituated to each dose level. For most people, nausea is worst in the first one to two weeks after a dose step-up and settles thereafter.

### How long do side effects last with oral Wegovy?

GI side effects typically peak in the first one to two weeks after a dose increase, then reduce over the following two to three weeks as your body adjusts. At the maintenance dose of 25mg, the adjustment period may be longer — allow four to six weeks. If severe symptoms persist beyond this, contact your prescriber.

### Can I take anti-nausea medication with oral Wegovy?

Over-the-counter antiemetics such as cyclizine may be appropriate for managing short-term nausea, and ginger is a well-tolerated option for mild symptoms. Discuss any antiemetic use with your pharmacist or prescriber, particularly if you are taking other regular medicines, to check for interactions.

### Is it safe to continue taking oral Wegovy if I have nausea?

Mild to moderate nausea that does not prevent you eating or drinking is generally manageable and not a reason to stop. Severe nausea with repeated vomiting, or nausea accompanied by severe abdominal pain, warrants contacting your prescriber. Never stop and restart prescription medication without discussing it with your prescriber first.

### Are the side effects of Wegovy tablets different to the injection?

The GI side effect profile is broadly similar between tablet and injection. The tablet’s daily dosing means some people experience more day-to-day variation in nausea intensity compared to the weekly injection. Both formulations carry the same rare serious risks, including pancreatitis and gallbladder-related events, and the same contraindications.

### Do side effects get worse at higher doses?

Side effects can increase when your dose steps up, as your body adjusts to the higher level of GLP-1 receptor activity. This is expected and is why the escalation schedule builds slowly over twelve weeks. The adjustment period at each new dose level is usually temporary. If you consistently cannot tolerate a dose increase, discuss a slower escalation schedule with your prescriber.

—

*This article is for informational purposes only and does not constitute medical advice. Wegovy tablets (oral semaglutide) are a prescription-only medicine available in the UK. Always consult a registered UK healthcare professional before starting any weight management treatment. If you experience any concerning symptoms while taking oral Wegovy, contact your prescriber or seek medical attention. CompareWegovyPrices.co.uk is not affiliated with Novo Nordisk.*